Subscribe To Our Free Newsletter |
Aurobindo Pharma gains after Q3 PAT soars to Rs 936 cr
Aurobindo Pharma rose 2.69% to Rs 1029 after the company's consolidated net profit surged 90.6% to Rs 936 crore in Q3 FY24 as compared with Rs 491 crore in Q3 FY23.